Literature DB >> 8219607

Proposal of a risk score for recurrence in patients with curatively resected gastric cancer.

T Ichikura1, K Fujino, H Ikawa, S Tomimatsu, K Uefuji, S Tamakuma.   

Abstract

In this study, 168 patients who underwent curative resection for gastric cancer with prognostic serosal invasion [ps(+)] and 150 without prognostic serosal invasion [ps(-)] were analyzed separately to determine the prognostic importance of clinicopathological factors, and identify which patients were at high risk of recurrence. A multivariate analysis of survival time using Cox's proportional hazard model revealed the important prognostic factors to be: Lymph node involvement, the classification of gross appearance, macroscopic serosal invasion, and interstitial connective tissue in the ps(+) group; and lymph node involvement, macroscopic serosal invasion, and venous invasion in the ps(-) group. We proposed a risk score of recurrence based on the results of a further multivariate analysis called Hayashi's Quantification Analysis II, in which recurrence was chosen as an objective variable and the above prognostic factors were chosen as explanatory variables. Eighty-four percent of the patients with a score of 0 or higher in the ps(+) group and 83% of those with a score of +6 or higher in the ps(-) group showed recurrence. Thus, we believe that this score is useful for identifying those patients at high risk of recurrence, who should receive intensive chemotherapy even after curative resection.

Entities:  

Mesh:

Year:  1993        PMID: 8219607     DOI: 10.1007/bf00311616

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer.

Authors:  S Abe; M Shiraishi; S Nagaoka; H Yoshimura; D K Dhar; T Nakamura
Journal:  Surgery       Date:  1991-05       Impact factor: 3.982

2.  Lymph node involvement as the only prognostic factor in curative resected gastric carcinoma: a multivariate analysis.

Authors:  S Msika; C Chastang; S Houry; F Lacaine; M Huguier
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

3.  Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses.

Authors:  H Baba; D Korenaga; T Okamura; A Saito; K Sugimachi
Journal:  Arch Surg       Date:  1989-09

4.  [Clinico-pathological study on recurrent gastric cancer after curative resection].

Authors:  K Takeshita; H Habu; M Sunagawa; N Saitoh; Y Satoh; M Endoh
Journal:  Nihon Geka Gakkai Zasshi       Date:  1988-02

5.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

6.  [Evaluation of prognostic factors in surgery of gastric cancer].

Authors:  A Cavallaro; F Agresta; S Rizzo; V Di Giovanni
Journal:  G Chir       Date:  1989-03

7.  Human gastric carcinoma: prognosis in relation to macroscopic and microscopic features of the primary tumor.

Authors:  M Okada; S Kojima; M Murakami; T Fuchigami; T Yao; T Omae; A Iwashita
Journal:  J Natl Cancer Inst       Date:  1983-08       Impact factor: 13.506

8.  Evaluation of the prognostic factors in gastric cancer: the effect of chemotherapy on survival.

Authors:  D Cunningham; D Hole; D J Taggart; M Soukop; D C Carter; C S McArdle
Journal:  Br J Surg       Date:  1987-08       Impact factor: 6.939

9.  5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.

Authors:  J S MacDonald; P S Schein; P V Woolley; T Smythe; W Ueno; D Hoth; F Smith; M Boiron; C Gisselbrecht; R Brunet; C Lagarde
Journal:  Ann Intern Med       Date:  1980-10       Impact factor: 25.391

10.  Improved combination chemotherapy in advanced gastric cancer.

Authors:  J A Levi; D N Dalley; R S Aroney
Journal:  Br Med J       Date:  1979-12-08
View more
  2 in total

1.  Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer.

Authors:  T Suzuki; T Ochiai; H Hayashi; K Nakajima; A Yasumoto; E Hishikawa; H Shimada; F Horiuchi; S Ohki; K Isono
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Proposal for a clinicopathological prognostic score for resected gastric cancer patients.

Authors:  Cristina DIaz Del Arco; Lourdes Estrada Muñoz; Elena Molina Roldán; Luis Ortega Medina; Soledad García Gómez de Las Heras; Ángela Chávez; MaJesús Fernández Aceñero
Journal:  Saudi J Gastroenterol       Date:  2021 Jan-Feb       Impact factor: 2.485

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.